tirzepatide first‑line obesity
Tirzepatide Outgrows Semaglutide - A Weight Loss Shock
In 2024 tirzepatide delivered a 27.4% mean weight loss after just 90 days, outpacing semaglutide’s 19.1% in the same period. Real-world data show the dual agonist can also improve blood sugar and lower heart risk, making it a compelling option for patients who need rapid results. Medical